{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9BRP0",
      "entity_text" : "OVOL2",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_0062" ],
      "TissueType" : [ "tissuelist:TS-1224" ],
      "CellType" : [ "cl:CL:0000066" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "We approached the discovery of the MET signature by over-expression of OVOL1, OVOL2, or both OVOLs in the mesenchymal prostate cancer (PC3-EMT14) and breast cancer (MDA-MB-231) cell lines.",
  "reading_complete" : "2020-08-03T19:48:20Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T19:39:44Z",
  "trigger" : "over-expression",
  "evidence" : [ "over-expression of OVOL1, OVOL2" ],
  "pmc_id" : "4008156",
  "score" : 0
}